50 μg
Anti-SARS-CoV-2 (COVID-19) Nucleocapsid Protein (NP) Monoclonal Antibody
Purified mouse monoclonal antibody (IgG) raised against a synthetic peptide corresponding to aa 300-400 of Nucleocapsid Protein from SARS-CoV-2 (COVID-19) and demonstrating limited cross-reactivity with nucleoproteins from SARS and MERS.
Concentration: 1 mg/ml
Clonality: Monoclonal
Clone: 6F10
Form in stock: Purified
Host: Mouse
Clone: 6F10
Immunogen: Synthetic peptide targeting amino acids 300-400 of SARS-CoV-2 Nucleocapsid Protein.
Clonality: Monoclonal
Isotype: IgG
Purification: Purified from ascites by Protein G, purity >95% based on SDS-PAGE.
Conjugation: Unconjugated
Alternative names: COVID-19 COV-2
Notes: Antibody solution should be gently mixed before use.
Shipping: Gel Pack
Storage: Store at -20ºC. Product is stable for 6 weeks at 2-8ºC as undiluted liquid. Prepare fresh dilutions for every new experiment. Avoid freeze/thaw cycles.
Regulatory/ Restrictions: For Research Use Only.
Application: Suggested Dilution
Western Blot: 0.1-1 μg/ml
Indirect ELISA: 0.2-2 μg/ml (as detecting antibody)
Sandwich ELISA: 2 μg/ml
Immunohistochemistry: Assay dependent (not recommended without antigen retrieval)
 | Western Blot Analysis of purified recombinant Nucleoproteins from SARS, MERS and SARS-CoV-2 using Anti-SARS-CoV-2 NP Antibody [Clone 6F10] (BSV-COV-AB-08). Primary antibody concentration used was 0.1-1 μg/ml. |